Apimeds Pharmaceuticals US APUS
NYSE APUS
$4.84 +0.45 (+10.25%)
At close: Aug 21, 2026 · 4:00 PM EDT

Apimeds Pharmaceuticals US (APUS) Enterprise Value (QoQ) (2025)

Apimeds Pharmaceuticals US (APUS) Enterprise Value (QoQ) (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.51 Bn 43.55 Bn -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 Apimeds Pharmaceuticals US 8.00 Mn 8.00 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -37.93%
Sep 30, 2025 20.02%
Jun 30, 2025 -3,389.36%
Mar 31, 2025 -7,145.79%